AMPL Capital Limited has reported a significant financial turnaround for FY26, posting a consolidated Profit After Tax of Rs 25.01 crore against a loss of Rs 6.74 crore in the previous year. The firm also announced its 36th Annual General Meeting scheduled for September 25, 2026, where shareholders will vote on the re-appointment of the Managing Director and several key board members. The company recently completed a name change from Credent Global Finance and successfully issued 1 crore equity shares to institutional investors.
AMPL Capital FY26 Results and AGM Updates
Consolidated Profit After Tax: Rs 2,500.79 Lakh
Total Revenue: Rs 4,871.90 Lakh
Reader Takeaway: Strong operational turnaround with consolidated profitability; market awaits in-principle approval for MD’s preferential warrant issuance.
What just happened
AMPL Capital Limited (formerly Credent Global Finance) has released its annual financial results for the fiscal year ending March 31, 2026. The company successfully shifted from a consolidated loss of Rs 6.74 crore in the prior fiscal year to a profit of Rs 25.01 crore. Standalone results were equally robust, with Profit After Tax rising significantly to Rs 27.96 crore.
Why this matters
The financial shift reflects improved operational efficiency and a successful equity raise. The company issued 1 crore equity shares to qualified institutional buyers at Rs 30 per share during the year, strengthening its capital base to support future growth objectives.
Corporate Developments
The company will conduct its 36th Annual General Meeting (AGM) via video conferencing on September 25, 2026. Key agenda items include:
- Re-appointment of Managing Director Aditya Vikram Kanoria for a three-year term starting November 2026.
- Re-appointment of Independent Directors Shubhangi Agarwal and Sulabh Jain.
- Approval of material related-party transactions for FY27, each capped at Rs 10 crore, involving various group entities.
- Appointment of M/s. Mayuri Sinha & Co. as the new secretarial auditor.
Risks to watch
While operational performance has improved, the company is still awaiting in-principle approval from BSE Limited regarding the issuance of 76 lakh convertible equity warrants to the Managing Director. Any regulatory delay in this approval process may impact investor sentiment regarding promoter-led capital infusions.
What to track next
Investors should monitor the outcome of the upcoming AGM, particularly the shareholder vote on related-party transactions and the status of the pending BSE warrant approval. The impact of the name change and the strategic direction under the re-appointed board will be critical for long-term valuation.